AI predicts breast cancer spread risk from tissue scans
Part of Cancer, Skin clinical trials.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older with invasive breast cancer confirmed by biopsy.
- You had surgery (mastectomy or lumpectomy) to remove your tumor between January 2015 and December 2025.
- A sample of your tumor is available before any chemotherapy or hormone therapy was started.
- Your medical team has detailed records of your cancer stage, hormone receptor status, and treatment history.
- You do not have cancer in the opposite breast or a history of other cancers (except cured skin or cervical cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze tissue samples from breast cancer that has spread to distant organs, like the liver or lungs. The goal is to develop a tool that predicts how breast cancer might spread, helping doctors personalize treatment.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
This trial uses artificial intelligence to predict if a cancer might spread to other parts of the body. It may help doctors catch metastasis earlier and improve treatment planning.
This study uses an artificial intelligence (AI) system to look at prostate biopsy samples and predict if the cancer has spread to the lymph nodes. It may help doctors decide on the best treatment without needing extra surgery or scans.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.